CD4-CD8- T-cell polymyositis in a patient with chronic active Epstein-Barr virus infection

American Journal of Hematology

Volumn 71, Issue 3, 2002, Pages 211-215

  Tsutsumi, Sachiko ^a   Ohga, Shouichi ^a   Nomura, Akihiko ^a   Takada, Hidetoshi ^a   Sakai, Shuji ^a   Ohshima, Koichi ^b   Sumimoto, Kotoko ^c   Hara, Toshiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c Dept of Internal Medicine   (Japan)

Author keywords

T cells; Chronic active Epstein Barr virus infection; Myositis

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN; PREDNISOLONE; VIRUS DNA; VIRUS RNA;

ADOLESCENT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; CLUBBING FINGERS; CYANOSIS; CYTOPENIA; EPSTEIN BARR VIRUS; FEMALE; FEVER; HEPATOSPLENOMEGALY; HUMAN; HUMAN TISSUE; LIVER DYSFUNCTION; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; NATURAL KILLER CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMYOSITIS; PRIORITY JOURNAL; SYMPTOM; T LYMPHOCYTE; VIRUS INFECTION;

ADOLESCENT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; POLYMYOSITIS;

EID: 0036830107     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10207     Document Type: Article

References (24)

1. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000;343:481-492.
2. Kawa K. Epstein-Barr virus-associated diseases in humans. Int J Hematol 2000;71:108-117.
3. Knowles DM. Immunodeficiency-associated lymphoproliferative disorders. Mod Pathol 1999;12:200-217.
4. Okano M, Matsumoto S, Osato T, Sakiyama Y, Thiele GM, Purtilo DT. Severe chronic active Epstein-Barr virus infection syndrome. Clin Microbiol Rev 1991;4:129-135.
5. Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, Morishima T. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 2001;98:280-286.
6. + T-cell lymphoproliferative disorder following acute/chronic EBV infection: A distinct clinicopathologic syndrome. Blood 2000;96: 443-451.
7. Hohlfeld R, Engel AG. The role of γδT lymphocytes in inflammatory muscle disease. Chem Immunol 1992;53:75-85.
8. Ohga S, Nomura A, Takada H, Ihara K, Kawakami K, Yanai F, Takahata Y, Tanaka T, Kasuga N, Hara T. Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection. J Infect Dis 2001;183:1-7.
9. Ohshima K, Suzumiya J, Sugihara M, Nagafuchi S, Ohga S, Kikuchi M. CD95(Fas) ligand expression of Epstein-Barr virus (EBV)-infected lymphocytes: A possible mechanism of immune evasion in chronic active EBV infection. Pathol Int 1999;49:9-13.
10. Kluin PM, Feller A, Gaulard P, Jaffe ES, Meijer CJ, Muller- Hermelink HK, Pileri S. Peripheral T/NK-cell lymphoma: A report of the IXth Workshop of the European Association for Haematopathology. Histopathology 2001;38:250-270.
11. Weidmann E. Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia 2000;14:991-997.
12. de Wolf-Peeters C, Achten R. γδ T-cell lymphomas: A homogeneous entity? Histopathology 2000;36:294-305.
13. Kagami Y, Nakamura S, Suzuki R, Yatabe Y, Okada Y, Kobayasi T, Taniwaki M, Seto M, Ogura M, Suchi T. A nodal γδ T-cell lymphoma with an association of Epstein-Barr virus. Am J Surg Pathol 1997;21: 729-736.
14. Arnulf B, Copie-Bergman C, Delfau-Larue MH, Lavergne-Slove A, Bosq J, Wechsler J, Wassef M, Matuchansky C, Epardeau B, Stern M, Bagot M, Reyes F, Gaulard P. Nonhepatosplenic γδ T-cell lymphoma: A subset of cytotoxic lymphomas with mucosal or skin localization. Blood 1998;91:1723-1731.
15. Lavergne A, Brocheriou I, Delfau MH, Copie-Bergman C, Houdart R, Gaulard PH. Primary intestinal γδ T-cell lymphoma with evidence of Epstein-Barr virus. Histopathology 1998;32:271-276.
16. Toro JR, Beaty M, Sorbara L, Turner ML, White J, Kingma DW, Raffeld M, Jaffe ES. γδ T-cell lymphoma of the skin: A clinical, microscopic, and molecular study. Arch Dermatol 2000;136:1024-1032.
17. Ohshima K, Haraoka S, Harada N, Kamimura T, Suzumiya J, Kanda M, Kawasaki C, Sugihara M, Kikuchi M. Hepatosplenic γδ T-cell lymphoma: Relation to Epstein-Barr virus and activated cytotoxic molecules. Histopathology 2000;36:127-135.
18. Ohno T, Komada F, Yamaguchi M, Oka K, Nishii K, Tsuda M, Katsuta K, Yamaguchi T, Kita K, Shirakawa S. Gamma/delta T-cell lymphoma with hepatosplenomegaly: Report of a case. Int J Hematol 1993; 57:269-276.
19. Ohtsuka M, Iwatsuki K, Kaneko R, Akiba H, Kikuchi S, Harada H, Kaneko F. Epstein-Barr virus-associated lymphoid hyperplasia of the eyelid characterized by intramuscular infiltration. Br J Dermatol 1999; 140:358-359.
20. Pluschke G, Ruegg D, Hohlfeld R, Engel AG. Autoaggressive myocytotoxic T lymphocytes expressing an unusual γδ T cell receptor. J Exp Med 1992;176:1785-1789.
21. Rothenberg ME, Weber WE, Longtine JA, Hafler DA, Cytotoxic γδ T lymphocytes associated with an Epstein-Barr virus-induced posttransplantation lymphoproliferative disorder. Clin Immunol Immunopathol 1996;80:266-272.
22. Takada H, Ohga S, Mizuno Y, Suminoe A, Matsuzaki A, Ihara K, Kinukawa N, Ohshima K, Kohno K, Kurimoto M, Hara T. Oversecretion of interleukin-18 in hemophagocytic lymphohistiocytosis: A novel marker of disease activity. Br J Hematol 1999;106:182-189.
23. Kasahara Y, Yachie A, Takei K, Kanegane C, Okada K, Ohta K, Seki H, Igarashi N, Maruhashi K, Katayama K, Katoh E, Terao G, Sakiyama Y, Koizumi S. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 2001;98: 1882-1888.
24. Imai S, Sugiura M, Oikawa O, Koizumi S, Hirao M, Kimura H, Hayashibara H, Terai N, Tsutsumi H, Oda T, Chiba S, Osato T. Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection. Blood 1996;87:1446-1457.